Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110.
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3532-7. doi: 10.1073/pnas.1401417111. Epub 2014 Feb 18.
The lysosomal storage disorder mucolipidosis III αβ is caused by mutations in the αβ subunits of UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase (phosphotransferase). This Golgi-localized enzyme mediates the first step in the synthesis of the mannose 6-phosphate recognition marker on lysosomal acid hydrolases, and loss of function results in impaired lysosomal targeting of these acid hydrolases and decreased lysosomal degradation. Here we show that two patient missense mutations, Lys4Gln and Ser15Tyr, in the N-terminal cytoplasmic tail of the α subunit of phosphotransferase impair retention of the catalytically active enzyme in the Golgi complex. This results in mistargeting of the mutant phosphotransferases to lysosomes, where they are degraded, or to the cell surface and release into the medium. The finding that mislocalization of active phosphotransferase is the basis for mucolipidosis III αβ in a subset of patients shows the importance of single residues in the cytoplasmic tail of a Golgi-resident protein for localization to this compartment.
溶酶体贮积症 IIIαβ 是由 UDP-GlcNAc:溶酶体酶 N-乙酰氨基葡萄糖-1-磷酸转移酶(磷酸转移酶)的αβ亚基的突变引起的。这种定位于高尔基体的酶介导了溶酶体酸性水解酶上甘露糖 6-磷酸识别标记合成的第一步,功能丧失导致这些酸性水解酶的溶酶体靶向受损和溶酶体降解减少。在这里,我们表明磷酸转移酶α亚基的 N 端细胞质尾部的两个患者错义突变,Lys4Gln 和 Ser15Tyr,会损害催化活性酶在高尔基体复合物中的保留。这导致突变磷酸转移酶错误靶向溶酶体,在那里它们被降解,或靶向细胞表面并释放到培养基中。在一组患者中,活性磷酸转移酶的定位错误是溶酶体贮积症 IIIαβ 的基础,这表明高尔基体驻留蛋白的细胞质尾部的单个残基对于该隔室的定位非常重要。